相关实验视频
Updated: Jan 14, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
23.0K
在患有异常性帕金森病的患者中,外周细胞因子水平经历了亚thalamic核深度大脑刺激
Ersoy Kocabıcak1, Sedat Sen2, Hafize Uzun3
1Department of Neurosurgery, Faculty of Medicine, Istanbul Atlas University, Istanbul, Turkey. ersoy.kocabicak@atlas.edu.tr.
Scientific reports
|October 21, 2025
概括
在帕金森病 (PD) 患者中,深部大脑刺激下丘脑核 (STN-DBS) 显著改善了运动症状. 然而,这种治疗不会改变外围细胞因子水平,这表明免疫调节不是临床益处的主要机制.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 涉及多巴胺能神经元退化,影响运动控制.
- 脑下核深脑刺激 (STN-DBS) 是高级PD的关键治疗方法.
- STN-DBS的次要影响,特别是对外围免疫标记物的次要影响,尚未完全理解.
研究的目的:
- 调查STN-DBS对异常病性PD患者的外周促炎和抗炎细胞因子水平的影响.
- 为了确定细胞因子水平的变化是否与STN-DBS后的临床改善相关.
主要方法:
- 这项研究包括32名患有异常性PD的患者,接受STN-DBS治疗.
- 评估了统一的帕金森病评分表 (UPDRS) 运动分数,LEDD,贝克抑郁 inventory (BDI) 和迷你精神状态检查 (MMSE).
- 在手术前和后测量了血清中细胞因子 (IL-1β,IL-6,IL-10,TNF-α) 的水平.
主要成果:
- STN-DBS导致UPDRS电机分数显著改善 (60.8%至71.3%),LEDD减少,BDI和MMSE分数得到改善.
- 在整个研究期间,血清细胞因子水平 (IL-1β,IL-6,IL-10,TNF-α) 没有观察到统计学上显著的变化.
- 在外围细胞因子水平和临床结果之间没有发现相关性.
结论:
- STN-DBS是有效和安全的改善运动症状在异常性PD,减少药物需求,并提高认知.
- 外周细胞因子水平保持不变,这表明临床益处不太可能通过直接的外周免疫调节来调节.
- 需要对更大的队列进行进一步的研究,以探索潜在的复杂免疫机制.
相关概念视频
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

